XVIVO PERFUSION AB NPVXX

XVIVO PERFUSION AB NPV

492.5SEKD
+1.5+0.35%
At close at Jan 10, 17:37 UTC
SEK
No trades
See on Supercharts
Back

Total liabilities of XVIVO PERFUSION AB NPV

Annual data
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
‪0.00‬
‪‪80.00 M‬‬
‪‪160.00 M‬‬
‪‪240.00 M‬‬
‪‪320.00 M‬‬
Period
Value
Change
Change %
2023
‪‪250.57 M‬‬
‪‪−52.38 M‬‬
‪−17.29‬%
2022
‪‪302.95 M‬‬
+‪‪45.80 M‬‬
+‪17.81‬%
2021
‪‪257.15 M‬‬
+‪‪115.30 M‬‬
+‪81.28‬%
2020
‪‪141.85 M‬‬
+‪‪84.88 M‬‬
+‪149.00‬%
2019
‪‪56.97 M‬‬
+‪‪10.83 M‬‬
+‪23.48‬%
2018
2017
2016
2015
2014
2013
Quarterly data
Q1 '17
Q2 '17
Q3 '17
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪80.00 M‬‬
‪‪160.00 M‬‬
‪‪240.00 M‬‬
‪‪320.00 M‬‬
Period
Value
Change
Change %
Q3 '24
‪‪195.02 M‬‬
‪‪−53.17 M‬‬
‪−21.42‬%
Q2 '24
‪‪248.19 M‬‬
‪‪−2.36 M‬‬
‪−0.94‬%
Q1 '24
‪‪250.54 M‬‬
‪‪−24.00 K‬‬
‪−0.01‬%
Q4 '23
‪‪250.57 M‬‬
‪‪−58.43 M‬‬
‪−18.91‬%
Q3 '23
‪‪308.99 M‬‬
+‪‪23.90 M‬‬
+‪8.38‬%
Q2 '23
‪‪285.10 M‬‬
‪‪−7.89 M‬‬
‪−2.69‬%
Q1 '23
‪‪292.99 M‬‬
‪‪−9.96 M‬‬
‪−3.29‬%
Q4 '22
‪‪302.95 M‬‬
+‪‪43.08 M‬‬
+‪16.58‬%
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q3 '21
Q2 '21
Q1 '21
Q4 '20
Q3 '20
Q2 '20
Q1 '20
Q4 '19
Q3 '19
Q2 '19
Q1 '19
Q4 '18
Q3 '18
Q2 '18
Q1 '18
Q4 '17
Q3 '17
Q2 '17
Q1 '17